Changchun High-Tech Industry (Group) Co., Ltd. (SHE: 000661)

Market Cap	31.79B
Revenue (ttm)	15.04B
Net Income (ttm)	4.09B
Shares Out	402.05M
EPS (ttm)	9.99
PE Ratio	7.92
Forward PE	6.82
Dividend	4.50 (5.67%)
Ex-Dividend Date	Apr 18, 2024

Volume	1,829,899
Open	80.49
Previous Close	79.39
Day's Range	78.89 - 80.49
52-Week Range	78.60 - 165.73
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2024

About Changchun High-Tech Industry (Group)

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products; and antibody and other chemical drugs. It also develops real estate properties. Changchun High-Tech Industry (Group) Co., Ltd. was founded in 1993 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 9,029
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2023, Changchun High-Tech Industry (Group)'s revenue was 14.57 billion, an increase of 15.35% compared to the previous year's 12.63 billion. Earnings were 4.53 billion, an increase of 9.47%.